Impact of the SARS-CoV-2 pandemic on the survival of patients with high-grade glioma and best practice recommendations

[1]  N. Ngandu,et al.  Hospital acquired COVID-19 infections amongst patients before the rollout of COVID-19 vaccinations, a scoping review , 2022, BMC Infectious Diseases.

[2]  A. Azzam,et al.  Impact of COVID-19 pandemic on the management of glioma patients around the world. An evidence-based review , 2021, Brain Disorders.

[3]  V. Paudyal,et al.  Cancer Services During the COVID-19 Pandemic: Systematic Review of Patient’s and Caregiver’s Experiences , 2021, medRxiv.

[4]  G. Reifenberger,et al.  EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood , 2020, Nature Reviews Clinical Oncology.

[5]  M. Strawderman,et al.  Time to treatment initiation and outcomes in high-grade glioma patients in rehabilitation: a retrospective cohort study , 2020, CNS oncology.

[6]  M. Callery,et al.  Gastrointestinal Malignancies and the COVID-19 Pandemic: Evidence-Based Triage to Surgery , 2020, Journal of Gastrointestinal Surgery.

[7]  M. Costantini,et al.  International guidelines and recommendations for surgery during Covid-19 pandemic: A Systematic Review , 2020, International Journal of Surgery.

[8]  P. Wen,et al.  Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas , 2020, Neuro-oncology.

[9]  A. Moinzadeh,et al.  Considerations in the Triage of Urologic Surgeries During the COVID-19 Pandemic , 2020, European Urology.

[10]  Steven P. Cohen,et al.  Pain Management Best Practices from Multispecialty Organizations during the COVID-19 Pandemic and Public Health Crises , 2020, Pain medicine.

[11]  Emeka Nkenke,et al.  Approaches to the management of patients in oral and maxillofacial surgery during COVID-19 pandemic , 2020, Journal of Cranio-Maxillofacial Surgery.

[12]  P. Allen,et al.  Optimal Timing of Radiotherapy Following Gross Total or Subtotal Resection of Glioblastoma: A Real-World Assessment using the National Cancer Database , 2020, Scientific Reports.

[13]  E. Holmes,et al.  A new coronavirus associated with human respiratory disease in China , 2020, Nature.

[14]  Siddhartha Ghosh,et al.  Delay in adjuvant chemoradiation impacts survival outcome in glioblastoma multiforme patients , 2020, Acta oncologica.

[15]  Peter Nakaji,et al.  Survival Outcomes Among Patients With High-Grade Glioma Treated With 5-Aminolevulinic Acid–Guided Surgery: A Systematic Review and Meta-Analysis , 2019, Front. Oncol..

[16]  H. Oliveira,et al.  Survival after radiation therapy for high-grade glioma. , 2019, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

[17]  T. Lawrie,et al.  Interval brain imaging for adults with cerebral glioma. , 2018, The Cochrane database of systematic reviews.

[18]  Jae-Sung Park,et al.  Effect of a time delay for concomitant chemoradiation after surgery for newly diagnosed glioblastoma: A single-institution study with subgroup analysis according to the extent of tumor resection. , 2019, World neurosurgery.

[19]  N. Kitchen,et al.  The impact of route of diagnosis on survival in patients with glioblastoma , 2018, British journal of neurosurgery.

[20]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[21]  Dennis Andersson,et al.  A retrospective cohort study , 2018 .

[22]  Susan M. Chang,et al.  Improved Survival with Decreased Wait Time to Surgery in Glioblastoma Patients Presenting with Seizure , 2017, Neurosurgery.

[23]  G. Reifenberger,et al.  European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. , 2017, The Lancet. Oncology.

[24]  Thomas C. Chen,et al.  Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial. , 2015, JAMA.

[25]  S. Short,et al.  Diagnostic delay and survival in high-grade gliomas – evidence of the ‘waiting time paradox’? , 2014, British journal of neurosurgery.

[26]  G. Reifenberger,et al.  EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. , 2014, The Lancet. Oncology.

[27]  L. Tanoue,et al.  The National Comprehensive Cancer Network , 1998, Cancer.

[28]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[29]  H. Armah.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial , 2010 .

[30]  R. Mirimanoff,et al.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.

[31]  Henry Brem,et al.  Independent association of extent of resection with survival in patients with malignant brain astrocytoma. , 2009, Journal of neurosurgery.

[32]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2004, Journal international de bioethique = International journal of bioethics.

[33]  N. Laperriere,et al.  Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  E. Glaser.  The randomized clinical trial. , 1972, The New England journal of medicine.